- BPH
- Benign Prostatic Hyperplasia
- Bladder Cancer
- Bladder Dysfunction
- Overactive Bladder
- Prostate Cancer
- Sexual Dysfunction
- Urinary Tract Infection
- Urolithiasis
Webcasts
Expert's Viewpoint
- Experts’ Bytes on BPH: Duration of Prescription for Alpha Blocker Monotherapy and Alpha Blocker-5ARI Combination Therapy.
- Experts’ Bytes on BPH: Lifestyle Modification Tips for Patients with LUTS due to BPH
- Experts’ Bytes on BPH: Importance of Taking Medical History in LUTS
- Experts’ Bytes on BPH: Prevalence of LUTS in General Population
- Experts’ Bytes on BPH: Causes of LUTS other than BPH
- Experts’ Bytes on BPH: What is the general protocol for following up with patients with BPH or LUTS? Which investigation is to be repeated and how often?
- Experts’ Bytes on BPH: In our daily practice we get geriatric patients. Do you recommend the Serum PSA test to these regular patients not suffering from LUTS rather coming for a problem related to neurological, cardiological etc?
- Experts’ Bytes on BPH: If Patient Coming with Fever Has Some Symptoms but Urine Doesn’t Show Anything, How Do You Approach Them in Making the Diagnosis?
- Experts’ Bytes on BPH: In Addition to The Management Of OAB, Do We Need to Check the Urine Flow Through Uroflowmetry Test and PVR Volume Through Abdominal Ultrasound?
- Experts’ Bytes on BPH: How to manage Overactive Bladder or Bothered Storage Symptoms?
- Experts’ Bytes on BPH: How to Approach the Status Post Prostatectomy with LUTS?
- Experts’ Bytes on BPH: How Long Should We Continue Drugs for LUTS?
Key Trials
- Efficacy Evaluation of Solifenacin and Tamsulosin Combination Therapy vs. Tamsulosin Monotherapy
- Silodosin, An Efficacious and Safe Drug for Relief from Nocturia Due to BPH
- Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Unsatisfactory Response to Initial Αlpha1 Blocker Therapy: The SPLASH Study
- Tamsulosin Reduces Night Time Urine Production in Nocturnal Polyuria Due to BPH: A Single-Arm, Open-Label, Prospective Study
__07.10.2020.jpg)
Webcasts
- Differential Diagnoses & Medical Management of LUTS During Scenario of Social Distancing
- Cross-fires in Urology: Medical Therapy vs Surgical Therapy for BPH
- What’s New on the Horizon in the Medical Management of BPH?
- Changing Landscape in the Surgical Management of BPH
- Alpha-blockers in Medical Practice: Balancing Efficacy vs Safety
- Progress in Medical Management of BPH
Expert's Viewpoint
- Experts’ Bytes on BPH: Duration of Prescription for Alpha Blocker Monotherapy and Alpha Blocker-5ARI Combination Therapy.
- Experts’ Bytes on BPH: Lifestyle Modification Tips for Patients with LUTS due to BPH
- Experts’ Bytes on BPH: Importance of Taking Medical History in LUTS
- Experts’ Bytes on BPH: Prevalence of LUTS in General Population
- Experts’ Bytes on BPH: Causes of LUTS other than BPH
- Webinar Snippet: Collation Of Excerpts Of Dr Sanjay Sinha’s Webcast Talk On The Management Of LUTS With Selected Responses To Audience Queries
- Webinar Snippet: Applicability Of Urodynamic Studies In Patients With BPH / LUTS
- Webinar Snippet: What Is The Treatment Of Bedwetting In Children?
- Webinar Snippet: What Is The Treatment Of A Weak Detrusor?
- Webinar Snippet: 5-Alpha Reductase Inhibitors & Their Effect On Serum PSA In BPH
- Webinar Snippet: Case Study: Management Of A Patient With Frequency & Urgency
- Webinar Snippet: Case Study: Management Of A Patient With Nocturia
- Webinar Snippet: Case Study: Management Of A Patient With Voiding Difficulty
- Webinar Snippet: How Should Voiding And Storage LUTS Be Managed Medically?
- Webinar Snippet: What Are The Various Lifestyle Modifications To Be Suggested To A Patient Of BPH / LUTS?
- Webinar Snippet: Importance Of Serum PSA Vs DRE In Suspecting Prostate Cancer
- Webinar Snippet: Asymptomatic Bacteriuria: Definition & Latest Understanding On Its Management
- Webinar Snippet: PVR: What It Is & Its Upper Limit Cut-Off?
- Webinar Snippet: Nocturia And Its Various Causes
- Webinar Snippet: Lower Urinary Tract Symptoms (LUTS): Definition, Medical Importance And Relation With BPH / BPE / BOO
- Webinar Snippet: What Are The Implications And Significance Of Storage Symptoms?
Key Trials
- Mirabegron Add-on Therapy Safe and Effective in Men Receiving Tamsulosin for LUTS Associated with BPH
- Efficacy Evaluation of Solifenacin and Tamsulosin Combination Therapy vs. Tamsulosin Monotherapy
- Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Unsatisfactory Response to Initial Αlpha1 Blocker Therapy: The SPLASH Study
- Enhanced Outcome with Silodosin
- Thermoexpandable Metallic Temporary Prostate Stent (TEmt), An Effective and Safe Alternative to Long-term Foley Catheterization in Elderly Men with Urethral Obstruction
- Superior Long-Term Clinical Outcomes with HoLEP as Compared to TURP in the Treatment of Benign Prostate Hyperplasia
- Non-inferiority of Low Power to High Power Holmium Laser Enucleation of the Prostate in BPH
- Safety and Efficacy of Tadalafil Combined with α-Blocker in Benign Prostatic Hyperplasia Patients with Erectile Dysfunction
Webcasts
Key Trials
- A New Urine DNA mutation Detection Test Offers Promise in Detecting Recurrence in Non-Muscle-Invasive Bladder Cancer
- Efficacy and Safety of Intravesical Bacillus Calmette-Guérin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria (ABU)
- Recent Therapeutic Updates on Non-Muscle Invasive Bladder Cancer (NMIBC)
- Transurethral Endoscopic Thulium Laser En Bloc Resection of Non-Muscle-Invasive Bladder Cancer Avoids Repeat Transurethral Resection
- Narrow Band Imaging Might be a Promising Diagnostic Intervention in Non-Muscle Invasive Bladder Cancer
- Survival Outcomes with Extended and Limited Lymph Node Dissection in Bladder Cancer Patients undergoing Radical Cystectomy
- BCG Therapy Significantly Reduced Recurrence and Progression in High Risk Non-Muscle-Invasive Bladder Cancer
- Significant Reduction in the Risk of Treatment Failure with Bacillus Calmette-Guerin Therapy Compared to Chemotherapy in Carcinoma in Situ of the Bladder
.jpg)
Conference Proceedings
Guidelines
- NCCN: Clinical Practice Guidelines in Oncology (2021)
- ESMO: Bladder Cancer Treatment Recommendations (2020)
- Cancer Guideline Resource Centre
- ISCCM: End of Life Care Policy for the Dying: Consensus Position Statement of Indian Association of Palliative Care (2014)
- International Bladder Cancer Group - Defining and Treating the Spectrum of Intermediate-Risk NMIBC (2012-2013)
Key Trials
Conference Proceedings
Clinical Tools
Guidelines
- EAU: Urinary Incontinence – European Association of Urology (2017)
- AUA/SUFU: Guideline on Diagnosis and Treatment Of Overactive Bladder (Non-Neurogenic) in Adults (2015)
- EAU: Guidelines on Urinary Incontinence (2014)
- EAU: Guidelines on Chronic Pelvic Pain (2014)
- AUA: Guideline on Surgical Management of Female Stress Urinary Incontinence: Update 2009
Key Trials
- Safety and Efficacy of Mirabegron Compared to Antimuscarinics in Older Subjects with Overactive Bladder
- Mirabegron Add-on Therapy Safe and Effective in Men Receiving Tamsulosin for LUTS Associated with BPH
- Useful Predictors in Analysing the Presence of Detrusor Overactivity in Male Patients with Lower Urinary Tract Symptoms
- Efficacy, Safety and Cognitive Effects of Solifenacin in Elderly
- Vibegron Significantly Reduces Urgency Urinary Incontinence in Overactive Bladder
- Cough Stress Tests to Detect Stress Urinary Incontinence in Women with Pelvic Organ Prolapse Before and After Surgery
- Vibegron: New Therapeutic Option for Improving Nocturia in Overactive Bladder
- Alfuzosin or Tamsulosin Might Improve Resolution of Urinary Retention Secondary to Benign Prostatic Obstruction
- Efficacy of Intravesical Instillation of Onabotulinum Toxin A in Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome is Limited
.jpg)
Webcasts
- New Approaches Towards Treating Men with Metastatic Prostate Cancer
- Sequencing in Prostate Cancer: An Update
- Updates in the Management of Prostate Cancer
- Hormonal Therapy in Management of Prostate Cancer: The Evolving Role
- CRPC: Adapting to New Treatment Paradigms
- Managing CRPC – Current Challenges (Panel Discussion)
- Clinical Appraisal of Abiraterone Acetate in the Management of CRPC (Panel Discussion)
- Early Stage Prostate Cancer Clinical Stage T1NOMO, Gleason 3+3. How Will I Manage?
- It's Time to Abandon the Upper Limit of Normal for PSA
- Management of CRPC: Where do we Stand in 2012?
- Dutasteride for Chemoprevention: Current Status and Future Prospects
Our Publications
Key Trials
- Local Salvage Therapies in Radiation Recurrent Prostate Cancer – Are they Beneficial?
- Oncological and Functional Outcomes with High-Intensity Focused Ultrasound in the Treatment of Prostate Cancer
- Non-Inferiority of Degarelix with Goserelin in Chinese Men with Prostate Cancer
- Improved Survival Outcomes with Androgen-Receptor-Axis-Targeted Therapies in Metastatic Castration-Sensitive Prostate Cancer
- AFFIRM Trial: Enzalutamide Significantly Prolonged Survival in Men with Metastatic Castration-Resistant Prostate Cancer After Chemotherapy
- PROSPER Trial: Enzalutamide Associated with Significantly Prolonged Overall Survival than Placebo in Men with Nonmetastatic, Castration-resistant Prostate Cancer Receiving Androgen-deprivation Therapy
- Salvage Radiotherapy along with Hormone Therapy Improves Outcomes in Prostate Specific Antigen Failure after Radical Prostatectomy
- PSMA-Guided Radiotherapy Offers Promise in Men with Oligorecurrent Prostate Cancer
- No Significant Changes in Lipid and Glucose Metabolism with Degarelix and Leuprolide Treatment in Prostate Cancer
- Addition of Docetaxel to Androgen Deprivation Therapy Improves Survival Outcomes and is Cost-Effective in Metastatic Prostate Cancer
- Apalutamide Prolongs Survival in Metastatic Castration-Sensitive Prostate Cancer: Findings of TITAN Trial
- Addition of Enzalutamide to Standard First-Line Therapy Prolongs Survival in Metastatic Prostate Cancer
- Early Use of Vacuum Therapy Has an Excellent Therapeutic Effect in Men undergoing Radical Prostatectomy
- Enzalutamide and Abiraterone Improved Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer
- LATITUDE Study: Abiraterone Plus Prednisone Might Be Clinically Beneficial in Men with Metastatic Castration-Sensitive Prostate Cancer
- Antiandrogen Therapy with Daily Bicalutamide and Radiation Therapy Improves Survival in Recurrent Prostate Cancer
- COU-AA-302: Abiraterone Acetate with Prednisone is Superior to Prednisone Alone in Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer Patients
Conference Proceedings
Guidelines
- ASCO: Initial Management of Non-Castrate Advanced, Recurrent or Metastatic Prostate Cancer (2021)
- ASCO : Initial Management of Non-Castrate Advanced, Recurrent or Metastatic Prostate Cancer (2021)
- NCCN: Clinical Practice Guidelines in Oncology (2021)
- AUA-ASTRO-SUO: Advanced Prostate Cancer Guidelines: A Continued but Changing Role for the Radiation Oncologist (2020)
- AUA: Castration-Resistant Prostate Cancer (2018)
- Cancer Guideline Resource Centre
- ISCCM: End of Life Care Policy for the Dying: Consensus Position Statement of Indian Association of Palliative Care (2014)
- AUA: Best Practice Statement on PSA Testing for the Pretreatment Staging and Posttreatment Management of Prostate Cancer (2013)
- AUA: Best Practice Statement on Cryosurgery for the Treatment of Localized Prostate Cancer (2010)
Key Trials
- Varicocele Repair in Infertile Men Increases Pregnancy and Live Birth Rate
- Reduced Penile Prosthesis Infection Rates with Intraoperative Irrigation using Vancomycin/Gentamicin vs Povidone-Iodine
- Synergistic Effect of Tadalafil and L-arginine in Erectile Dysfunction
- Daily Tadalafil More Effective than On-Demand Tadalafil in Long-Term Treatment of Erectile Dysfunction
- L-Carnitine and L-Acetylcarnitine, Beneficial in Men with Idiopathic Oligoasthenozoospermia
- Long Term Testosterone Therapy Clinically Beneficial in Hypogonadal Men
Conference Proceedings
Webcasts
- Management of Urinary Tract Infection in Women
- Complicated UTI & Urosepsis: Uro- Physician Perspectives
- Urinary Tract Infection in Children : How do I Investigate?
- Uncomplicated Cystitis: Current Concepts and Future Perspective
- Antibiotic Stewardship – A Must Do in the Era of Antibiotic Resistance (Panel Discussion)
- Fosfomycin: The Promising Antibiotic Therapy in the Management of UTI
- Urinary Tract Infection: The Indian Perspective
- Management of UTI What's New, What's True?
Expert's Viewpoint
- Webinar Snippet: Standard Management Protocol (Antibiotics/Prophylaxis/ Vaccine/Probiotics) & Cases Where Surgical Management is Needed
- Webinar Snippet: UTI in Diabetic Women - Case Illustrations
- Webinar Snippet: Assessment of UTI In Elderly Women
- Webinar Snippet: UTI in Elderly Women (Aging & Urinary Tract)
- Webinar Snippet: Pathophysiology & Predisposing Factors for UTI in Elderly Women
- Webinar Snippet: Fosfomycin in UTI – MOA, Dosage, Advantages & Place in Therapy
- Webinar Snippet: UTI & Its Recurrence in Pregnancy
- Webinar Snippet: Non-antibiotic Strategies for Prevention of UTI In Adolescent Girls and Females of Reproductive Age
- Webinar Snippet: Choosing an Antibiotic Treatment in Acute Uncomplicated Cystitis & Recurrent UTI In Adolescent Girls and Females of Reproductive Age
- Webinar Snippet: Acute Uncomplicated Cystitis in Adolescent Girls and Females of Reproductive Age – Diagnosis (History, Urine Analysis & Special Investigations)
- Webinar Snippet: Acute Uncomplicated Cystitis in Adolescent Girls and Females of Reproductive Age (Etiology, Risk factors & Clinical presentation)
- Management of Complicated UTI – A Case Discussion (Case 2)
- Management of Complicated UTI – A Case Discussion (Case 3)
- Management of Complicated UTI – A Case Discussion
Our Publications
- UTI: Physician Update
- Pocket Guidelines on Urological Infections
- MIC Series-Updates on UTI: Issue 12
- MIC Series-Updates on UTI: Issue 11
- MIC Series-Updates on UTI: Issue 10
- MIC Series-Updates on UTI: Issue 09
- MIC Series-Updates on UTI: Issue 08
- MIC Series-Updates on UTI: Issue 07
- MIC Series-Updates on UTI: Issue 06
- MIC Series-Updates on UTI: Issue 05
- MIC Series-Updates on UTI: Issue 04
- MIC Series-Updates on UTI: Issue 03
- MIC Series-Updates on UTI: Issue 02
- MIC Series-Updates on UTI: Issue 01
Key Trials
Conference Proceedings
Patient Education
Clinical Tools
Webcasts
- SUPERPERC- What, When and Why: Semi-Live Workshop
- Papillary Vs Non Papillary Puncture, RIRS- Current Concepts
- Recent Advances in ESWL
- Cross-fires in Urology: PCNL vs RIRS
- Urolithiasis: In Pursuit of Excellence
- Challenges in the Management of Urolithiasis: Integrating Perspectives
- Alpha Blockers: From Stone Cradle to Grave
- Crossfires in Urology: Standard PCNL versus Mini/Micro PCNL
- Optimizing Techniques in Urolithiasis
- Challenges in the Management of Urolithiasis (2016)
- Management of Ureteric Stones: Should It Be ESWL or Ureteroscopy?
- Recent Advances in Ureteral Stenting
- Crossfire – Controversies in the Management of Urolithiasis (Panel Discussion)
- Urological Surgeries: Optimizing Techniques (Video-session)
- A New Perspective in the Management of Urolithiasis